Emerging Trends and Innovations for the Antibody Discovery Market | projected to reach USD 13.7 Billion by 2030

According to a research report "Antibody Discovery Market, by Source (Humanized Antibody, Human Antibody, Chimeric Antibody and Murine Antibody), Antibody Type (Monoclonal Antibodies (mAbs), Polyclonal Antibodies and Recombinant Antibodies), Method (Phage Display, Hybridoma, Transgenic Antibody Technology, Single B Cell Technology and Others), End-user (Pharmaceutical & Biotechnology industry, Research laboratory and Academic laboratory) & Region - Global Forecast to 2030"

Antibody Discovery Market was valued USD 6.9 Billion in 2023 and projected to reach USD 13.7 Billion by 2030, growing at a CAGR of 9.0% during the forecast period of 2023-2030.

Download Sample Pages - https://www.marketdigits.com/request/sample/3712

Browse in-depth TOC on Antibody Discovery Market

• 324 - Tables
• 56 - Figures
• 370 - Pages

Market Overview: In recent years, the antibody discovery market has witnessed significant expansion, propelled by a growing need for precision therapeutics and the escalating incidence of chronic and infectious diseases. The process of antibody discovery entails the recognition and creation of antibodies designed to selectively bind to disease targets, presenting promising uses in diagnostics, therapeutics, and research. This market incorporates diverse technologies and platforms, including hybridoma technology, phage display, and transgenic animal models, facilitating the creation and enhancement of antibodies tailored for particular disease indications.

Market Dynamics

Drivers:

• Rising Prevalence of Chronic and Infectious Diseases
• Increasing Research and Development Investment
• Advancements in antibody engineering

Opportunities:

• Development of new antibody-based therapies
• Development of novel antibody discovery platforms
• Expansion into new therapeutic areas

North Americadominates the market for Antibody Discovery.

In 2022, the North American antibody discovery market is anticipated to dominate in the forecast period, propelled by an increase in cancer prevalence, a robust presence of the antibody discovery industry, and technological advancements in the R&D sector. For instance, in 2020, the American Cancer Society reported approximately 1.8 million new cancer cases and 606,520 cancer-related deaths in the U.S., underscoring the demand for therapeutic antibodies and stimulating market growth. The upsurge in funding facilitates the development of novel technologies, collaborative efforts spanning countries and organizations, and the exploration of existing antibody treatments, contributing to a deeper understanding of the immune system and the effective development of targeted antibodies. Moreover, augmented funding enables large-scale clinical trials essential for evaluating antibody efficacy, thereby enhancing the overall growth trajectory of the market.

On the other hand, the Asia-Pacific antibody discovery market is poised for expansion in the forecast period due to an increase in the incidence of cardiovascular diseases and other chronic health conditions. As reported by the Journal of Biomedical and Environmental Science in 2021, approximately 330 million individuals in China experienced cardiovascular diseases. The significance of antibody discovery becomes evident in the creation of innovative therapeutics for addressing cardiovascular ailments. Consequently, the rising prevalence of heart diseases amplifies the demand for antibody discovery, playing a pivotal role in propelling market growth.

Top Key Players covered in the market report:

• Biocytogen
• Charles River Laboratories
• Creative Biolabs
• Danaher Corporation
• Eurofins Scientific
• Evotec
• Fairjourney Biologics S.A
• Genscript Technology Corporation
• Sartorius AG
• Twist Bioscience

More for Information - Inquire Now!

Segmentations Analysis of Antibody Discovery Market: -

• By Source
• By Type
• By Technology
• By End-user
• By Region

About us:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

Contact Us: Email: sales@marketdigits.com